Cargando…
Prostate cancer cell phenotypes based on AGR2 and CD10 expression
The combination of expression patterns of AGR2 and CD10 by prostate cancer provided four phenotypes that correlated with clinical outcome. Based on immunophenotyping, CD10(low)AGR2(high), CD10(high)AGR2(high), CD10(low)AGR2(low), and CD10(high)AGR2(low) were distinguished. AGR2(+) tumors were associ...
Autores principales: | Ho, Melissa E., Quek, Sue-Ing, True, Lawrence D., Morrissey, Colm, Corey, Eva, Vessella, Robert L., Dumpit, Ruth, Nelson, Peter S., Maresh, Erin L., Mah, Vei, Alavi, Mohammed, Kim, Sara R., Bagryanova, Lora, Horvath, Steve, Chia, David, Goodglick, Lee, Liu, Alvin Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638070/ https://www.ncbi.nlm.nih.gov/pubmed/23348903 http://dx.doi.org/10.1038/modpathol.2012.238 |
Ejemplares similares
-
High expression of AGR2 in lung cancer is predictive of poor survival
por: Alavi, Mohammed, et al.
Publicado: (2015) -
Differential expression of anterior gradient gene AGR2 in prostate cancer
por: Maresh, Erin L, et al.
Publicado: (2010) -
Protein expression based multimarker analysis of breast cancer samples
por: Presson, Angela P, et al.
Publicado: (2011) -
Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status
por: Mah, Vei, et al.
Publicado: (2015) -
Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2
por: Ho, Melissa E., et al.
Publicado: (2016)